BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 80 hits of ic50 data for polymerid = 50002231   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50090529
PNG
(2-[1-(Naphthalene-1-sulfonyl)-1H-indol-6-yl]-octah...)
Show SMILES O=S(=O)(c1cccc2ccccc12)n1ccc2ccc(cc12)N1CCN2CCCC2C1
Show InChI InChI=1S/C25H25N3O2S/c29-31(30,25-9-3-6-19-5-1-2-8-23(19)25)28-14-12-20-10-11-21(17-24(20)28)27-16-15-26-13-4-7-22(26)18-27/h1-3,5-6,8-12,14,17,22H,4,7,13,15-16,18H2
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
MCE
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 7.20n/an/an/an/an/an/a



NPS Allelix Corp.

Curated by ChEMBL


Assay Description
Antagonistic activity of the compound evaluated in adenylyl cyclase assay


Bioorg Med Chem Lett 10: 1719-21 (2000)


BindingDB Entry DOI: 10.7270/Q2BP021W
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128187
PNG
((1R,3R)-3-(6-Amino-purin-9-yl)-cyclopentanecarboxy...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@@H](C1)C(=O)NO
Show InChI InChI=1S/C11H14N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h4-7,19H,1-3H2,(H,16,18)(H2,12,13,14)/t6-,7-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 200n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128192
PNG
((1S,3R)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@@H](CC(=O)NO)C=C1 |c:20|
Show InChI InChI=1S/C12H14N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 400n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128210
PNG
((1R,3R)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](CC(=O)NO)C1
Show InChI InChI=1S/C12H16N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 600n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128207
PNG
((1S,3S)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@@H](CC(=O)NO)C=C1 |c:20|
Show InChI InChI=1S/C12H14N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 2.60E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128209
PNG
((1R,3S)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@H](CC(=O)NO)C=C1 |c:20|
Show InChI InChI=1S/C12H14N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 4.30E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128203
PNG
((1R,3S)-3-(6-Amino-purin-9-yl)-cyclopentanecarboxy...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@H](C1)C(=O)NO
Show InChI InChI=1S/C11H14N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h4-7,19H,1-3H2,(H,16,18)(H2,12,13,14)/t6-,7+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.60E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128199
PNG
((1S,3S)-4-(6-Amino-purin-9-yl)-cyclopent-2-enecarb...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](C=C1)C(=O)NO |c:15|
Show InChI InChI=1S/C11H12N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h1-2,4-7,19H,3H2,(H,16,18)(H2,12,13,14)/t6-,7-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.90E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119826
PNG
(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Show SMILES Nc1ncnc2n(CCCCC(=O)NO)cnc12
Show InChI InChI=1S/C10H14N6O2/c11-9-8-10(13-5-12-9)16(6-14-8)4-2-1-3-7(17)15-18/h5-6,18H,1-4H2,(H,15,17)(H2,11,12,13)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 7.60E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119826
PNG
(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Show SMILES Nc1ncnc2n(CCCCC(=O)NO)cnc12
Show InChI InChI=1S/C10H14N6O2/c11-9-8-10(13-5-12-9)16(6-14-8)4-2-1-3-7(17)15-18/h5-6,18H,1-4H2,(H,15,17)(H2,11,12,13)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 7.60E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119826
PNG
(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Show SMILES Nc1ncnc2n(CCCCC(=O)NO)cnc12
Show InChI InChI=1S/C10H14N6O2/c11-9-8-10(13-5-12-9)16(6-14-8)4-2-1-3-7(17)15-18/h5-6,18H,1-4H2,(H,15,17)(H2,11,12,13)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 7.60E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells


Bioorg Med Chem Lett 12: 3085-8 (2002)


BindingDB Entry DOI: 10.7270/Q2XW4J5B
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119832
PNG
(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Show SMILES Nc1ncnc2n(CCCC(=O)NO)cnc12
Show InChI InChI=1S/C9H12N6O2/c10-8-7-9(12-4-11-8)15(5-13-7)3-1-2-6(16)14-17/h4-5,17H,1-3H2,(H,14,16)(H2,10,11,12)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 7.90E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119832
PNG
(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Show SMILES Nc1ncnc2n(CCCC(=O)NO)cnc12
Show InChI InChI=1S/C9H12N6O2/c10-8-7-9(12-4-11-8)15(5-13-7)3-1-2-6(16)14-17/h4-5,17H,1-3H2,(H,14,16)(H2,10,11,12)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 7.90E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells


Bioorg Med Chem Lett 12: 3085-8 (2002)


BindingDB Entry DOI: 10.7270/Q2XW4J5B
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119832
PNG
(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Show SMILES Nc1ncnc2n(CCCC(=O)NO)cnc12
Show InChI InChI=1S/C9H12N6O2/c10-8-7-9(12-4-11-8)15(5-13-7)3-1-2-6(16)14-17/h4-5,17H,1-3H2,(H,14,16)(H2,10,11,12)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 7.90E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128188
PNG
((1S,3R)-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl]-...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@@H](CC(O)=O)C=C1 |c:19|
Show InChI InChI=1S/C12H13N5O2/c13-11-10-12(15-5-14-11)17(6-16-10)8-2-1-7(3-8)4-9(18)19/h1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 8.20E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128206
PNG
((1S,3S)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@H](CC(=O)NO)C1
Show InChI InChI=1S/C12H16N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 9.40E+3n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128191
PNG
(2-[3-(6-Amino-purin-9-yl)-cyclopentyloxy]-N-hydrox...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@@H](C1)OCC(=O)NO
Show InChI InChI=1S/C12H16N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 1.08E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119858
PNG
(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](C1)OCC(=O)NO
Show InChI InChI=1S/C12H16N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 1.08E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119858
PNG
(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](C1)OCC(=O)NO
Show InChI InChI=1S/C12H16N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 1.08E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119855
PNG
(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](OCC(=O)NO)C=C1 |c:21|
Show InChI InChI=1S/C12H14N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 1.36E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119855
PNG
(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](OCC(=O)NO)C=C1 |c:21|
Show InChI InChI=1S/C12H14N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 1.36E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128205
PNG
(2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyloxy]-N-h...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@@H](OCC(=O)NO)C=C1 |c:21|
Show InChI InChI=1S/C12H14N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 1.36E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119844
PNG
(2-{[2-(6-Amino-purin-9-yl)-ethyl]-methyl-amino}-N-...)
Show SMILES CN(CCn1cnc2c(N)ncnc12)CC(=O)NO
Show InChI InChI=1S/C10H15N7O2/c1-16(4-7(18)15-19)2-3-17-6-14-8-9(11)12-5-13-10(8)17/h5-6,19H,2-4H2,1H3,(H,15,18)(H2,11,12,13)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 1.53E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells


Bioorg Med Chem Lett 12: 3085-8 (2002)


BindingDB Entry DOI: 10.7270/Q2XW4J5B
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128204
PNG
((1R,3R)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](CC(=O)NO)C=C1 |c:20|
Show InChI InChI=1S/C12H14N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 1.63E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128202
PNG
((1R,3S)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@@H](CC(=O)NO)C1
Show InChI InChI=1S/C12H16N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 2.51E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128195
PNG
((1R,3R)-[3-(6-Amino-purin-9-yl)-cyclopentyl]-aceti...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](CC(O)=O)C1
Show InChI InChI=1S/C12H15N5O2/c13-11-10-12(15-5-14-11)17(6-16-10)8-2-1-7(3-8)4-9(18)19/h5-8H,1-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 2.88E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119842
PNG
(6-(6-Amino-purin-9-yl)-hexanoic acid hydroxyamide ...)
Show SMILES Nc1ncnc2n(CCCCCC(=O)NO)cnc12
Show InChI InChI=1S/C11H16N6O2/c12-10-9-11(14-6-13-10)17(7-15-9)5-3-1-2-4-8(18)16-19/h6-7,19H,1-5H2,(H,16,18)(H2,12,13,14)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 3.54E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119842
PNG
(6-(6-Amino-purin-9-yl)-hexanoic acid hydroxyamide ...)
Show SMILES Nc1ncnc2n(CCCCCC(=O)NO)cnc12
Show InChI InChI=1S/C11H16N6O2/c12-10-9-11(14-6-13-10)17(7-15-9)5-3-1-2-4-8(18)16-19/h6-7,19H,1-5H2,(H,16,18)(H2,12,13,14)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 3.54E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells


Bioorg Med Chem Lett 12: 3085-8 (2002)


BindingDB Entry DOI: 10.7270/Q2XW4J5B
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119842
PNG
(6-(6-Amino-purin-9-yl)-hexanoic acid hydroxyamide ...)
Show SMILES Nc1ncnc2n(CCCCCC(=O)NO)cnc12
Show InChI InChI=1S/C11H16N6O2/c12-10-9-11(14-6-13-10)17(7-15-9)5-3-1-2-4-8(18)16-19/h6-7,19H,1-5H2,(H,16,18)(H2,12,13,14)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.54E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128197
PNG
((1S,3R)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@H](CC(=O)NO)C1
Show InChI InChI=1S/C12H16N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 5.50E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128201
PNG
((1S,3R)-3-(6-Amino-purin-9-yl)-cyclopentanecarboxy...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](C1)C(=O)NO
Show InChI InChI=1S/C11H14N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h4-7,19H,1-3H2,(H,16,18)(H2,12,13,14)/t6-,7+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a>7.00E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119853
PNG
(2-{[(1S,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@H](OCC(O)=O)C=C1 |c:20|
Show InChI InChI=1S/C12H13N5O3/c13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19/h1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 7.20E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128190
PNG
((1S,3S)-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl]-...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@@H](CC(O)=O)C=C1 |c:19|
Show InChI InChI=1S/C12H13N5O2/c13-11-10-12(15-5-14-11)17(6-16-10)8-2-1-7(3-8)4-9(18)19/h1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15)/t7-,8+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 7.32E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128186
PNG
((1S,3S)-3-(6-Amino-purin-9-yl)-cyclopentanecarboxy...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@H](C1)C(=O)NO
Show InChI InChI=1S/C11H14N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h4-7,19H,1-3H2,(H,16,18)(H2,12,13,14)/t6-,7-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 7.80E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119860
PNG
(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](OCC(O)=O)C=C1 |c:20|
Show InChI InChI=1S/C12H13N5O3/c13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19/h1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15)/t7-,8+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 7.80E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119857
PNG
(CHEMBL108067 | [(S)-3-((S)-6-Amino-purin-9-yl)-cyc...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](C1)OCC(O)=O
Show InChI InChI=1S/C12H15N5O3/c13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19/h5-8H,1-4H2,(H,18,19)(H2,13,14,15)/t7-,8+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 7.90E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119821
PNG
(2-[3-(6-Amino-purin-9-yl)-propoxy]-N-hydroxy-aceta...)
Show SMILES Nc1ncnc2n(CCCOCC(=O)NO)cnc12
Show InChI InChI=1S/C10H14N6O3/c11-9-8-10(13-5-12-9)16(6-14-8)2-1-3-19-4-7(17)15-18/h5-6,18H,1-4H2,(H,15,17)(H2,11,12,13)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 9.40E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119821
PNG
(2-[3-(6-Amino-purin-9-yl)-propoxy]-N-hydroxy-aceta...)
Show SMILES Nc1ncnc2n(CCCOCC(=O)NO)cnc12
Show InChI InChI=1S/C10H14N6O3/c11-9-8-10(13-5-12-9)16(6-14-8)2-1-3-19-4-7(17)15-18/h5-6,18H,1-4H2,(H,15,17)(H2,11,12,13)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 9.40E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells


Bioorg Med Chem Lett 12: 3085-8 (2002)


BindingDB Entry DOI: 10.7270/Q2XW4J5B
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119854
PNG
(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@@H](OCC(=O)NO)C=C1 |c:21|
Show InChI InChI=1S/C12H14N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 9.60E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119861
PNG
(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@@H](OCC(O)=O)C=C1 |c:20|
Show InChI InChI=1S/C12H13N5O3/c13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19/h1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15)/t7-,8+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 9.80E+4n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128194
PNG
((1R,3R)-4-(6-Amino-purin-9-yl)-cyclopent-2-enecarb...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@@H](C=C1)C(=O)NO |c:15|
Show InChI InChI=1S/C11H12N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h1-2,4-7,19H,3H2,(H,16,18)(H2,12,13,14)/t6-,7-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 1.00E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128189
PNG
((1S,3S)-[3-(6-Amino-purin-9-yl)-cyclopentyl]-aceti...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@H](CC(O)=O)C1
Show InChI InChI=1S/C12H15N5O2/c13-11-10-12(15-5-14-11)17(6-16-10)8-2-1-7(3-8)4-9(18)19/h5-8H,1-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a>1.00E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119854
PNG
(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@@H](OCC(=O)NO)C=C1 |c:21|
Show InChI InChI=1S/C12H14N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 1.02E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119851
PNG
(2-[(R)-3-((R)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@H](C1)OCC(=O)NO
Show InChI InChI=1S/C12H16N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a 1.10E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119829
PNG
(CHEMBL104969 | [3-(6-Amino-purin-9-yl)-propoxy]-ac...)
Show SMILES Nc1ncnc2n(CCCOCC(O)=O)cnc12
Show InChI InChI=1S/C10H13N5O3/c11-9-8-10(13-5-12-9)15(6-14-8)2-1-3-18-4-7(16)17/h5-6H,1-4H2,(H,16,17)(H2,11,12,13)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 1.41E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells


Bioorg Med Chem Lett 12: 3085-8 (2002)


BindingDB Entry DOI: 10.7270/Q2XW4J5B
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50128211
PNG
((1S,3R)-4-(6-Amino-purin-9-yl)-cyclopent-2-enecarb...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@@H](C=C1)C(=O)NO |c:15|
Show InChI InChI=1S/C11H12N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h1-2,4-7,19H,3H2,(H,16,18)(H2,12,13,14)/t6-,7+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.88E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells.


J Med Chem 46: 2177-86 (2003)


Article DOI: 10.1021/jm0205604
BindingDB Entry DOI: 10.7270/Q2M32V44
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119856
PNG
(CHEMBL106689 | [(R)-3-((R)-6-Amino-purin-9-yl)-cyc...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@H](C1)OCC(O)=O
Show InChI InChI=1S/C12H15N5O3/c13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19/h5-8H,1-4H2,(H,18,19)(H2,13,14,15)/t7-,8+/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a>2.00E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119859
PNG
(2-{[(1R,3R)-3-(6-amino-9H-purin-9-yl)cyclopentyl]o...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@H](C1)OCC(O)=O
Show InChI InChI=1S/C12H15N5O3/c13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19/h5-8H,1-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a>2.00E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119850
PNG
(2-{[(1R,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@@H](OCC(O)=O)C=C1 |c:20|
Show InChI InChI=1S/C12H13N5O3/c13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19/h1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a>2.00E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Adenylate cyclase type 5


(Homo sapiens (Human))
BDBM50119852
PNG
(2-{[(1S,3S)-3-(6-amino-9H-purin-9-yl)cyclopentyl]o...)
Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@@H](C1)OCC(O)=O
Show InChI InChI=1S/C12H15N5O3/c13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19/h5-8H,1-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

PubMed
n/an/a>2.00E+5n/an/an/an/an/an/a



Millennium Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme


Bioorg Med Chem Lett 12: 3089-92 (2002)


BindingDB Entry DOI: 10.7270/Q2T43SFX
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 80 total )  |  Next  |  Last  >>
Jump to: